[Restricted mean duration of response: a novel endpoint for efficacy evaluation in oncology clinical trials].
- DOI
- 10.3760/cma.j.cn112338-20250619-00412
- Published
- 2026 Feb 10
- Container
- Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3760/cma.j.cn112338-20250619-00412,
title = {[Restricted mean duration of response: a novel endpoint for efficacy evaluation in oncology clinical trials].},
author = {Kong XX and Huang RY and Wang YF and Chen C and Ni SM and Yu H and Zuo JW and Yu H and Zhong ZH and Bai JL},
year = {2026},
journal = {Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi},
doi = {10.3760/cma.j.cn112338-20250619-00412},
url = {https://doi.org/10.3760/cma.j.cn112338-20250619-00412}
}RIS
TY - JOUR TI - [Restricted mean duration of response: a novel endpoint for efficacy evaluation in oncology clinical trials]. AU - Kong XX AU - Huang RY AU - Wang YF AU - Chen C AU - Ni SM AU - Yu H AU - Zuo JW AU - Yu H AU - Zhong ZH AU - Bai JL PY - 2026 JO - Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi DO - 10.3760/cma.j.cn112338-20250619-00412 UR - https://doi.org/10.3760/cma.j.cn112338-20250619-00412 ER -
APA
XX, K., RY, H., YF, W., C, C., SM, N., H, Y., JW, Z., H, Y., ZH, Z., & JL, B. (2026). [Restricted mean duration of response: a novel endpoint for efficacy evaluation in oncology clinical trials].. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. https://doi.org/10.3760/cma.j.cn112338-20250619-00412
Source records
- pubmed · retrieved 2026-09-26T13:40:36.742Z
- europe-pmc · retrieved 2026-09-26T13:40:36.741Z